Clinical Trial Update: Moderate to Severe Bronchiolitis: Standard Therapy Versus Therapy With NaCl 3% Inhalations [Phase 3]

View source ↗

Summary

This Phase 3 trial compares standard therapy with added hypertonic saline (3%) inhalations for moderate to severe bronchiolitis. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchiolitis

Drugs mentioned

• Hypertonic saline 3% inhalation (sodium chloride 3% inhalation solution)

Snippet

Sponsor: Raphaelle Jaquet-Pilloud | Conditions: Moderate to Severe Bronchiolitis | Phase 3 | Status: COMPLETED